| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $-0.1B | $-0.1B | $-0.1B | $-0.2B | $0.1B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $-1.00 | $-1.46 | $-1.65 | $-3.47 | $1.83 | — | — | — |
| EPS (Diluted) | $-1.00 | $-1.46 | $-1.65 | $-3.47 | $1.83 | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.2B | $5.4B | $5.6B | $5.7B | $1.9B | $1.9B | $2.5B | $1.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $4.3B | $4.4B | $4.4B | $4.3B | $0.9B | $0.9B | $1.5B | $0.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.5B | $0.6B | $0.7B | $0.8B | $1.0B | $1.0B | $1.0B | $1.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $0.0B | $0.0B | $0.1B | $-3.4B | $0.0B | $-0.0B | $-0.9B | $-0.1B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.1B | $-0.0B | $0.0B | $3.5B | $-0.1B | $-0.1B | $0.8B | $0.0B |